top of page
  • Edward Vargas

Navigating New 340B Transparency Requirements: Strategies for Covered Entities

A professional auditor reviewing data sheets and graphs.

The recent bipartisan draft bill on the 340B Drug Pricing Program has introduced potential transparency requirements that could significantly impact how Covered Entities (CEs) report and utilize their 340B savings. This legislation aims to enhance the program's transparency by mandating detailed reporting on the use of 340B savings and making this information publicly available. Understanding and adapting to these changes is crucial for CEs to maintain compliance and optimize the benefits of the 340B program.


Understanding the Proposed Transparency Requirements


The draft bill proposes several key reporting requirements for CEs, including:

  • Annually report detailed information related to 340B program savings, policies, and patient and prescription information.

  • Specific data such as the number of individuals dispensed or administered 340B drugs, health insurance coverage types, charity care costs, patient demographics, contracts, a list of contract pharmacies, discounts realized, and the use of savings were included.

  • Separate reporting mechanisms for CEs not submitting Medicare cost reports and HHS's publication of reported information on a public website.


These requirements underscore the need for CEs to have robust mechanisms for tracking and reporting their 340B program activities and savings utilization.


A Three-Step Methodology for Determining Appropriate Use of 340B Savings


To navigate these proposed requirements, CEs can adopt a three-step methodology to ensure their 340B savings are used appropriately and in alignment with the proposed transparency standards:

  1. Identify and Categorize 340B Savings: Begin by accurately tracking and categorizing all 340B savings, distinguishing between savings used for patient care, administrative costs, and other program-related expenses.

  2. Evaluate and Document Savings Utilization: Assess how 340B savings enhance patient care and services. Document specific examples of how savings support underserved populations, improve patient outcomes, and reduce healthcare costs.

  3. Align Savings Use with Program Goals: Ensure that the utilization of 340B savings aligns with the overarching goals of the 340B program—increasing access to medications and healthcare services for vulnerable populations. Regularly review and adjust strategies to maintain alignment with these objectives.


Best-Practice Considerations


When determining the appropriate use of 340B savings, CEs should consider the following best practices:

  • Transparency and Accountability: Maintain transparent records of how 340B savings are utilized, ensuring accountability and readiness for potential audits.

  • Community Impact: Focus on using savings in ways that directly and positively impact patient care and community health outcomes.

  • Compliance and Documentation: Keep detailed documentation supporting compliance with current and future reporting requirements.


Hypothetical Examples and Application of Methodology


Example: A health center uses 340B savings to fund a free medication program for uninsured patients.


Application of Methodology:

  1. Identify and Categorize Savings: The center tracks the 340B savings allocated to the free medication program.

  2. Evaluate and Document Savings Utilization: The center documents the number of patients served, the types of medications provided, and the program's impact on patient health outcomes.

  3. Align Savings Use with Program Goals: The center reviews the program's alignment with 340B objectives, ensuring it effectively addresses the needs of underserved populations.


To navigate the complexities of the 340B program and leverage its benefits fully, it's essential to stay informed and proactive. For in-depth insights and strategies on managing your 340B program effectively:



By adopting a strategic approach to the newly proposed transparency requirements and leveraging expert resources, Covered Entities can continue to maximize the benefits of the 340B program while ensuring compliance and transparency.

bottom of page